A detailed history of Thoroughbred Financial Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Thoroughbred Financial Services, LLC holds 19,305 shares of LLY stock, worth $15.4 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
19,305
Previous 18,894 2.18%
Holding current value
$15.4 Million
Previous $17.1 Million 0.02%
% of portfolio
1.1%
Previous 1.14%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$772.14 - $960.02 $317,349 - $394,568
411 Added 2.18%
19,305 $17.1 Million
Q2 2024

Aug 08, 2024

BUY
$724.87 - $909.04 $3.59 Million - $4.5 Million
4,950 Added 35.5%
18,894 $17.1 Million
Q1 2024

May 07, 2024

SELL
$592.2 - $792.28 $2.14 Million - $2.86 Million
-3,609 Reduced 20.56%
13,944 $10.8 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $1.64 Million - $1.93 Million
3,115 Added 21.58%
17,553 $10.2 Million
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $1.39 Million - $1.92 Million
3,202 Added 28.5%
14,438 $7.76 Million
Q2 2023

Aug 03, 2023

BUY
$350.74 - $468.98 $697,972 - $933,270
1,990 Added 21.52%
11,236 $5.27 Million
Q1 2023

Apr 24, 2023

BUY
$310.63 - $364.82 $34,169 - $40,130
110 Added 1.2%
9,246 $3.18 Million
Q4 2022

Feb 07, 2023

SELL
$321.55 - $374.67 $6,431 - $7,493
-20 Reduced 0.22%
9,136 $3.34 Million
Q3 2022

Oct 27, 2022

BUY
$296.48 - $337.87 $1,482 - $1,689
5 Added 0.05%
9,156 $2.96 Million
Q2 2022

Aug 03, 2022

BUY
$278.73 - $327.27 $62,435 - $73,308
224 Added 2.51%
9,151 $2.97 Million
Q1 2022

May 04, 2022

BUY
$234.69 - $291.66 $602,449 - $748,691
2,567 Added 40.36%
8,927 $2.56 Million
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $60,934 - $75,619
271 Added 4.45%
6,360 $1.76 Million
Q3 2021

Oct 27, 2021

BUY
$221.6 - $272.71 $63,377 - $77,995
286 Added 4.93%
6,089 $1.41 Million
Q2 2021

Jul 27, 2021

BUY
$180.55 - $233.54 $15,527 - $20,084
86 Added 1.5%
5,803 $1.33 Million
Q1 2021

Apr 30, 2021

BUY
$164.32 - $212.72 $3,286 - $4,254
20 Added 0.35%
5,717 $1.07 Million
Q4 2020

Jan 26, 2021

SELL
$130.46 - $172.63 $20,612 - $27,275
-158 Reduced 2.7%
5,697 $962,000
Q3 2020

Oct 28, 2020

BUY
$146.22 - $169.13 $877 - $1,014
6 Added 0.1%
5,855 $866,000
Q2 2020

Jul 20, 2020

SELL
$136.42 - $164.18 $379,384 - $456,584
-2,781 Reduced 32.22%
5,849 $960,000
Q1 2020

Apr 23, 2020

BUY
$119.05 - $147.35 $116,311 - $143,960
977 Added 12.77%
8,630 $1.2 Million
Q4 2019

Feb 05, 2020

SELL
$106.92 - $132.43 $6,949 - $8,607
-65 Reduced 0.84%
7,653 $1.01 Million
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $747 - $813
7 Added 0.09%
7,718 $863,000
Q2 2019

Jul 16, 2019

SELL
$110.79 - $129.32 $93.8 Million - $109 Million
-846,692 Reduced 99.1%
7,711 $0
Q2 2019

Jul 16, 2019

BUY
$110.79 - $129.32 $93.8 Million - $110 Million
846,791 Added 11124.42%
854,403 $0
Q1 2019

May 07, 2019

BUY
$111.31 - $131.02 $11,687 - $13,757
105 Added 1.4%
7,612 $988,000
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $794,991 - $890,630
7,507 New
7,507 $868,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Thoroughbred Financial Services, LLC Portfolio

Follow Thoroughbred Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.